Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v12-EN | Version v8-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2021-06-17 | 2021-04-05 |
| Drug Identification Number | 02139480 | 02139480 |
| Brand name | FOLIC ACID INJECTION, USP | FOLIC ACID INJECTION, USP |
| Common or Proper name | Folic Acid Injection 5 mg/mL MD Vial 10 mL | Folic Acid Injection 5 mg/mL MD Vial 10 mL |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | FOLIC ACID | FOLIC ACID |
| Strength(s) | 5MG | 5MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 10 mL | 10 mL |
| ATC code | B03BB | B03BB |
| ATC description | VITAMIN B12 AND FOLIC ACID | VITAMIN B12 AND FOLIC ACID |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2021-04-01 | 2021-04-01 |
| Estimated end date | 2021-06-14 | 2021-06-14 |
| Actual end date | 2021-06-16 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Folic Acid Injection 5 mg/mL MD Vial 10 mL will be placed on 50% allocation effective April 1, 2021 to May 31, 2021 with an anticipated backorder effective June 1, 2021 to June 14, 2021. | Folic Acid Injection 5 mg/mL MD Vial 10 mL will be placed on 50% allocation effective April 1, 2021 to May 31, 2021 with an anticipated backorder effective June 1, 2021 to June 14, 2021. |
| Health Canada comments |